Bank of America Merrill Lynch is out with its report today on Mectronic MDT, maintaining Neutral.
In a note to clients, Bank of America Merrill Lynch writes, "Overall, MDT's top-line outlook is slightly below the group, its cash flow generation is well above average, its FX risk is low, and operating leverage
upside is below average. Taken together and put within the context of a company that is now hitting numbers consistently, we think MDT's discount to the group will fade over time, but we prefer other large-cap medtech names."
Shares of MDT closed Tuesday at $39.01, up 1.11% from Monday's close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorAnalyst RatingsBank of America Merrill LynchHealth CareHealth Care EquipmentMedtronic
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in